STOCK TITAN

Revolution Medicines: Baker Bros. reports 4.92% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Revolution Medicines, Inc. (RVMD) ownership amendment reports that Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker and Felix J. Baker may each be deemed beneficial owners of 10,637,318 shares, equal to 4.92% of the class. Those shares are directly held in aggregate by Baker Brothers Life Sciences, L.P. and 667, L.P. The percentage is based on 216,251,663 shares outstanding as of September 30, 2026. The reporting persons report sole voting and dispositive power over the shares; under management agreements, the funds’ general partners relinquished investment and voting authority to Baker Bros. Advisors LP.

Beneficial ownership 10,637,318 shares The same shares, held directly in aggregate by Baker Brothers Life Sciences, L.P. and 667, L.P., are attributed to each reporting person.
Ownership percentage 4.92% Reported for each reporting person.
Shares outstanding 216,251,663 shares As of September 30, 2026; used as the basis for the reported ownership percentage.
beneficial ownership regulatory
"may be deemed to be indirectly beneficially owned by the Reporting Persons"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Rule 13d-3 regulatory
"calculated in accordance with Rule 13d-3"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.
dispositive power regulatory
"Sole power to dispose or to direct the disposition"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RVMD shares do the reporting persons beneficially own?

The four reporting persons each reported beneficial ownership of 10,637,318 shares, equal to 4.92% of the class. The shares are directly held in aggregate by Baker Brothers Life Sciences, L.P. and 667, L.P., and the same shares are attributed to each reporting person.

What voting and dispositive power did the RVMD reporting persons report?

The reporting persons reported sole voting and dispositive power over 10,637,318 shares, with zero shared voting or dispositive power. Under management agreements, the funds’ general partners relinquished investment and voting authority to Baker Bros. Advisors LP, which has complete and unlimited discretion and authority over those matters.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





76155X100

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Baker Bros. Advisors LP
Signature:/s/ Scott L. Lessing
Name/Title:Scott L. Lessing/ President By: Baker Bros. Advisors (GP) LLC, its general partner
Date:11/16/2026
Baker Bros. Advisors (GP) LLC
Signature:/s/ Scott L. Lessing
Name/Title:Scott L. Lessing/ President
Date:11/16/2026
Julian C. Baker
Signature:/s/ Julian C. Baker
Name/Title:Julian C. Baker
Date:11/16/2026
Felix J. Baker
Signature:/s/ Felix J. Baker
Name/Title:Felix J. Baker
Date:11/16/2026

Keep reading